FDA Approves New Option in Obesity

The Allurion Gastric Balloon System is now authorized by the US Food and Drug Administration for short-term weight loss in adults aged 22 to 65 years with obesity and a body mass index of 30 to 40 kg/m2.

By
Kathryn Wighton
February 23, 2026
3 min

Conexiant

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

#1

Mayo Clinic

Rochester, MN
Key Differentiators
- Obesity Medicine
- Bariatric Surgery
- Metabolic Research
#2

Cleveland Clinic

Cleveland, OH
Key Differentiators
- Bariatric Surgery
- Obesity Medicine
- Endoscopic Weight Loss Procedures
#3

Johns Hopkins Medicine

Baltimore, MD
Key Differentiators
- Obesity Medicine
- Metabolic and Bariatric Surgery
- Clinical Trials
#4

Geisel School of Medicine at Dartmouth

Hanover, NH
Key Differentiators
- Obesity Medicine
- Clinical Research
#5

Massachusetts General Hospital

Boston, MA
Key Differentiators
- Obesity Medicine
- Bariatric Surgery
- Metabolic Research